Pharmaceutical Strategies Group
Business Services · Texas, United States · 156 Employees
View Company Info for Free
About
Headquarters
5360 Legacy Dr Ste 230 Bldg 3, Plano, Texas, 75...Phone Number
(800) 687-4404Website
www.psgconsults.comRevenue
$43.1 MillionIndustry
Most Recent Scoops
Who is Pharmaceutical Strategies Group
Pharmaceutical Strategies Group, an EPIC company, relentlessly advocates for clients as they navigate complex and ever-changing drug cost managemen t challenges. PSG's innovative drug management solutions, including the proprietary data and analytics platform, Artemetrx, deliver actionable insights with exceptional financial and clinical value. PSG functions as a strategic partner through industry-leading intelligence and technologies to realize billions of dollars in drug cost savings for clients every year.Read more
Popular SearchesPharmaceutical Strategies GroupPSG Support Services LLCPsg Consulting LLCPsg LLCPharmaceutical Strategies Group LLCSIC Code 87,874NAICS Code 54,541Show morePharmaceutical Strategies Group Org Chart
Is Pharmaceutical Strategies Group your ideal customer?
Let us give you the heads up on whether it's a good time to reach out
Click to see if Pharmaceutical Strategies Group had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Pharmaceutical Strategies Group has new funding data
Product Launch: Get notified when Pharmaceutical Strategies Group launches new products
Check if Pharmaceutical Strategies Group has recently received funding, and reach out quickly before it becomes old news!
Check out if Pharmaceutical Strategies Group is spiking on competitors!
Earning: See what the market has to say on Pharmaceutical Strategies Group recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Pharmaceutical Strategies Group, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Pharmaceutical Strategies Group
Recommended Actions
Find VP level buyers at Pharmaceutical Strategies Group
Find more new buyers
Similar Companies to Pharmaceutical Strategies Group
Analyze insights from companies similar to Pharmaceutical Strategies Group and make strategic comparisons based on performance, financial data, growth and unique benchmarks.
- Ramsell117$19.7M
- Wellpartner101$18.9M
- SUNRx131$81.3M
- Benenson Strategy Group76$22.3M
- Procare RX245$51.5M
- CaptureRx144$52.5M
- Healthesystems339$71.2M
- Medical Benefit Administrators100$22.7M
More similar companies
Pharmaceutical Strategies Group Employee Growth Rate
Percentage of growth
1st year Mask
2nd year Mask
Pharmaceutical Strategies Group Tech Stack
A closer look at the technologies used by Pharmaceutical Strategies Group
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Most Recent Scoops
Pharmaceutical Strategies Group News & Media
Pharmaceutical Strategies Group Releases Artemetrx State of Specialty Spend and Trend Report
DALLAS--(BUSINESS WIRE)--Pharmaceutical Strategies Group (“PSG”), an EPIC company, releases its proprietary Artemetrx® State of Specialty Spend and Trend report, sponsored by Walmart Specialty Pharmacy. In its eighth year, the report uses integrated pharmacy and medical claims data to provide a holistic view of specialty drug spend and trend. First published in 2017, this report is the sole comprehensive analysis of specialty drug spending, powered by the industry’s leading integrated dataset tPharmaceutical Strategies Group Publishes Annual Drug Benefit Design Report for 2024
DALLAS--(BUSINESS WIRE)--Pharmaceutical Strategies Group (“PSG”), an EPIC company, released its annual Trends in Drug Benefit Design Report, sponsored by Prescryptive Health, detailing the trends and leading strategies for traditional drug benefits. The research provides valuable insights about drug benefit design and management. Management of the pharmacy benefit continues to be a critical aspect of U.S. healthcare, and this report provides insights on how healthcare payers evolve their pharmaPharmaceutical Strategies Group Announces Strategic Leadership Enhancements to Meet Growing Client Needs
DALLAS--(BUSINESS WIRE)--Pharmaceutical Strategies Group (“PSG”), an EPIC company, has added two significant enhancements to its leadership team aimed at further empowering healthcare payers and driving innovation within the pharmacy benefits industry. The company welcomes Mike Sackett as SVP of Financial Analytics, Procurement, and Consulting Strategy and celebrates the well-deserved promotion of Rebekah Gregg to Chief Operating Officer. "The addition of Mike Sackett to our team and the promotManaging Total Cost of Care is a Top Goal but Access to Reliable Data is Challenging, the Latest Trends in Specialty Drug Benefits Report by Pharmaceutical Strategies Group (PSG) Found
DALLAS--(BUSINESS WIRE)--Pharmaceutical Strategies Group (“PSG”), an EPIC company, released its annual Trends in Specialty Drug Benefits Report, co-sponsored by Genentech, a member of the Roche Group, detailing the complexities of specialty drug access and affordability. The proprietary research spotlights how employers and health plans are navigating the increasingly complex landscape of specialty drug access for patients. The research delves into critical issues impacting access to and afford
Frequently Asked Questions Regarding Pharmaceutical Strategies Group
Pharmaceutical Strategies Group, an EPIC company, relentlessly advocates for clients as they navigate complex and ever-changing drug cost management challenges. PSG's innovative drug management solutions, including the proprietary data and analytics platform, Artemetrx, deliver actionable insights with exceptional financial and clinical value. PSG... Read More